Aldeyra Therapeutics Inc (ALDX)
3.93
-0.01
(-0.25%)
USD |
NASDAQ |
Apr 26, 16:00
4.10
+0.17
(+4.33%)
After-Hours: 20:00
Aldeyra Therapeutics Net Income (Quarterly): -4.753M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.753M |
| September 30, 2023 | -8.187M |
| June 30, 2023 | -8.987M |
| March 31, 2023 | -15.62M |
| December 31, 2022 | -12.90M |
| September 30, 2022 | -14.55M |
| June 30, 2022 | -17.78M |
| March 31, 2022 | -16.79M |
| December 31, 2021 | -15.75M |
| September 30, 2021 | -15.80M |
| June 30, 2021 | -14.94M |
| March 31, 2021 | -11.29M |
| December 31, 2020 | -11.29M |
| September 30, 2020 | -8.873M |
| June 30, 2020 | -7.520M |
| March 31, 2020 | -9.868M |
| December 31, 2019 | -13.16M |
| September 30, 2019 | -18.72M |
| June 30, 2019 | -13.33M |
| March 31, 2019 | -15.62M |
| December 31, 2018 | -10.63M |
| September 30, 2018 | -10.81M |
| June 30, 2018 | -9.050M |
| Date | Value |
|---|---|
| March 31, 2018 | -8.397M |
| December 31, 2017 | -6.954M |
| September 30, 2017 | -4.986M |
| June 30, 2017 | -5.309M |
| March 31, 2017 | -5.091M |
| December 31, 2016 | -4.651M |
| September 30, 2016 | -4.775M |
| June 30, 2016 | -4.303M |
| March 31, 2016 | -4.967M |
| December 31, 2015 | -4.356M |
| September 30, 2015 | -3.366M |
| June 30, 2015 | -2.232M |
| March 31, 2015 | -2.137M |
| December 31, 2014 | -2.445M |
| September 30, 2014 | -2.009M |
| June 30, 2014 | -1.135M |
| March 31, 2014 | 0.4018M |
| December 31, 2013 | 9.295M |
| September 30, 2013 | 9.309M |
| June 30, 2013 | -1.569M |
| March 31, 2013 | -3.975M |
| December 31, 2012 | -21.74M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-18.72M
Minimum
Sep 2019
-4.753M
Maximum
Dec 2023
-12.64M
Average
-13.16M
Median
Dec 2019
Net Income (Quarterly) Benchmarks
| AbbVie Inc | 822.00M |
| United Therapeutics Corp | 217.10M |
| Heron Therapeutics Inc | -10.72M |
| Esperion Therapeutics Inc | -56.34M |
| FibroGen Inc | -56.23M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 6.098M |
| EPS Diluted (Quarterly) | -0.08 |
| Enterprise Value | 103.78M |
| Earnings Yield | -16.28% |